054050 — NH NongwooBio Share Price
- KR₩110bn
- KR₩100bn
- KR₩159bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.38 | ||
| Price to Tang. Book | 0.39 | ||
| Price to Free Cashflow | 19.08 | ||
| Price to Sales | 0.69 | ||
| EV to EBITDA | 6.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.46% | ||
| Return on Equity | 4.65% | ||
| Operating Margin | 6.52% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 132,842.72 | 133,399.76 | 135,843.61 | 144,680.22 | 158,789.06 | n/a | n/a | 4.08% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -15.39 | +33.83 | -5.45 | +10.92 | -2.82 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NH NongwooBio Co Ltd, formerly Nong Woo Bio Co Ltd, is a Korea-based company principally engaged in the development, production and sale of seeds and agricultural materials. The Company operates its business through two segments. The Seed segment is engaged in the cultivation, production and sale of vegetable seeds such as peppers, radishes, cabbages, watermelons, tomatoes, pumpkins, cucumbers and onions. The Agricultural Material segment is engaged in the production and sale of topsoil, fertilizers and biochar used for cultivation.
Directors
- Yu Hyeon Choi CEO (55)
- Nam Sik Cho MDR (54)
- Hui Yeong Goh DRC (61)
- Yong Hui Kim DRC (60)
- Dae Hyeon Nam NID (62)
- Seong Ju Park NID (65)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- June 5th, 1990
- Public Since
- April 2nd, 2002
- No. of Shareholders
- 13,681
- No. of Employees
- 427
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 16,030,561

- Address
- 114-8, Central town-ro, Yeongtong-gu, SUWON, 16506
- Web
- https://www.nongwoobio.co.kr/
- Phone
- +82 312181117
- Auditors
- Deloitte Anjin LLC
Latest News for 054050
Upcoming Events for 054050
NH NongwooBio Co Ltd Extraordinary Shareholders Meeting
Q3 2026 NH NongwooBio Co Ltd Earnings Release
Q4 2026 NH NongwooBio Co Ltd Earnings Release
Similar to 054050
Asia Seed
Korea Exchange - KOSDAQ
B2En
Korea Exchange - KOSDAQ
Bifido
Korea Exchange - KOSDAQ
Bio Port Korea
Korea Exchange - KOSDAQ
BL PharmTech
Korea Exchange - KOSDAQ
FAQ
As of Today at 04:20 UTC, shares in NH NongwooBio are trading at KR₩6,870. This share price information is delayed by 15 minutes.
Shares in NH NongwooBio last closed at KR₩6,870 and the price had moved by -20.39% over the past 365 days. In terms of relative price strength the NH NongwooBio share price has underperformed the FTSE Developed Asia Pacific Index by -41.86% over the past year.
There is no consensus recommendation for this security.
Find out moreThe NH NongwooBio dividend yield is 3.64% based on the trailing twelve month period.
Last year, NH NongwooBio paid a total dividend of KR₩250, and it currently has a trailing dividend yield of 3.64%. We do not have any data on when NH NongwooBio is to next pay dividends.
We do not have data on when NH NongwooBio is to next pay dividends. The historic dividend yield on NH NongwooBio shares is currently 3.64%.
To buy shares in NH NongwooBio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩6,870, shares in NH NongwooBio had a market capitalisation of KR₩110bn.
Here are the trading details for NH NongwooBio:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 054050
Based on an overall assessment of its quality, value and momentum NH NongwooBio is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NH NongwooBio. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -18.72%.
As of the last closing price of KR₩6,870, shares in NH NongwooBio were trading -8.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NH NongwooBio PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩6,870.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NH NongwooBio's management team is headed by:
- Yu Hyeon Choi - CEO
- Nam Sik Cho - MDR
- Hui Yeong Goh - DRC
- Yong Hui Kim - DRC
- Dae Hyeon Nam - NID
- Seong Ju Park - NID





